|
Rank
|
2006 Impact Factor
|
Impact 2003-07
|
Impact 1981-2007
|
|
1
|
Lancet Infectious Dis.
(11.81)
|
Lancet Infectious Dis.
(18.45)
|
J. Infect. Diseases
(36.07)
|
|
2
|
Clin. Infect. Diseases
(6.19)
|
Clin. Infect. Diseases
(11.82)
|
Infection & Immunity
(30.26)
|
|
3
|
AIDS
(5.63)
|
AIDS
(11.01)
|
AIDS
(28.22)
|
|
4
|
J. Infect. Diseases
(5.36)
|
J. Infect. Diseases
(10.87)
|
JAIDS-J. Acq. Imm. Def.
(25.92)
|
|
5
|
Emerging Infect. Dis.
(5.09)
|
Emerging Infect. Dis.
(10.29)
|
Lancet Infectious Dis.
(23.66)
|
|
6
|
Antiviral Therapy
(4.98)
|
Infection & Immunity
(8.68)
|
Clin. Infect. Diseases
(22.90)
|
|
7
|
Curr. Op. Infect. Dis.
(4.80)
|
Curr. Op. Infect. Dis.
(8.66)
|
Infect. Agents & Dis.
(22.23)
|
|
8
|
AIDS Reviews
(4.02)
|
JAIDS-J. Acq. Imm. Def.
(7.62)
|
Emerging Infect. Dis.
(18.66)
|
|
9
|
Infection & Immunity
(4.00)
|
J. Antimicrob. Chemo.
(7.30)
|
AIDS Res. & Hum. Retro.
(17.30)
|
|
10
|
JAIDS-J. Acq. Imm. Def.
(3.95)
|
Antiviral Therapy
(6.45)
|
J. Antimicrob. Chemo.
(16.13)
|